Snowden Capital Advisors LLC Cerus Corp Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.81 - $6.99 $4,329 - $6,291
-900 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$5.97 - $7.93 $5,373 - $7,137
900 New
900 $6,000
Q1 2020

Jan 08, 2024
SELL
$2.87 - $5.49 $344,400 - $658,800
-120,000 Closed
0 $0
Q3 2019

Jan 08, 2024
BUY
$4.86 - $6.05 $495,720 - $617,100
102,000 Added 566.67%
120,000 $6.19 Million
Q2 2019

Jan 08, 2024
BUY
$4.51 - $6.6 $81,180 - $118,800
18,000 New
18,000 $6.75 Million

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email